Blue Water Vaccines (BWV) Stock Analysis

What Blue Water Vaccines does

Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.

Key metrics

ETFs linked to BWV

Broad-market and Healthcare sector ETFs an investor holding Blue Water Vaccines is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BWV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Blue Water Vaccines?

Blue Water Vaccines trades under the ticker BWV on NASDAQ.

Which exchange is BWV listed on?

BWV is listed on NASDAQ.

What sector does Blue Water Vaccines operate in?

Blue Water Vaccines is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BWV in a portfolio?

PortView shows BWV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.